Perma-Fix Signs Option Agreement To License Technology For Use In Proprietary Process To Produce Medical Isotopes

About Battelle

Battelle is the world's largest independent research and development organization with 22,000 employees in more than 130 locations worldwide.  Headquartered in Columbus, Ohio, Battelle manages or co-manages six national laboratories for the U.S. Department of Energy, including Pacific Northwest National Laboratory in Richland, Wash.   PNNL employs 4,900 staff, has an annual budget of nearly $1.1 billion, and has been managed by Battelle since the lab's inception in 1965.

This press release contains "forward-looking statements" which are based largely on the Company's expectations and are subject to various business risks and uncertainties, certain of which are beyond the company's control. Forward-looking statements generally are identifiable by use of the words such as "believe", "expects", "intends", "anticipate", "plans to", "estimates", "projects", and similar expressions.   Forward-looking statements include, but are not limited to : benefits to our new process, such as having the potential to alleviate the shortages of Tc-99m; this new technology easily deployed around the world; environmental benefits to our new process; ability to commercialize this technology; and that this new technology will benefit patients.  These forward-looking statements are intended to qualify for the safe harbors from liability established by the Private Securities Litigation Reform Act of 1995. While the Company believes the expectations reflected in this news release are reasonable, it can give no assurance such expectations will prove to be correct. There are a variety of factors which could cause future outcomes to differ materially from those described in this release, including, without limitation, future economic conditions; industry conditions; competitive pressures; our ability to apply and market this technology; acceptance of our new technology by the medical industry; changes to our existing permits by appropriate governmental authorities; changes to existing laws limiting the treatment, storage or disposal of the residue of Tc-99m; ability to utilize our new technology with the technology licensed from PNNL; and the additional factors referred to under "Special Note Regarding Forward-Looking Statements" of our 2010 Form 10-K.  The Company makes no commitment to disclose any revisions to forward-looking statements, or any facts, events or circumstances after the date hereof that bear upon forward-looking statements.

Please visit us on the World Wide Web at http://www.perma-fix.com.

« First ‹ Previous 1 2 3 4 Next › Last »